The effects of short-term raloxifene therapy on fibrinolysis markers: TAFI, tPA, and PAI-1


Ozeren M., Karahan S. C. , Ozgur M., Eminagaoglu S., Unsal M. A. , Baytan S. , ...Daha Fazla

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, cilt.84, ss.987-991, 2005 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 84 Konu: 10
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1111/j.0001-6349.2005.00817.x
  • Dergi Adı: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
  • Sayfa Sayıları: ss.987-991

Özet

Background. Markers of fibrinolysis, thrombin-activatable fibrinolysis inhibitor (TAFI), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1) levels were studied for the evaluation of short-term effects of raloxifene administration in postmenopausal women.